UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 931

Sortiert nach

Systematic review with meta‐analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (10), p.1291-1302

2017

Volltextzugriff (PDF)

Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (4), p.454-465

2018

Volltextzugriff (PDF)

Ulcerative proctitis: Challenges for clinical management

Journal of gastroenterology and hepatology, 2023-07, Vol.38 (7), p.1192-1192

2023

Volltextzugriff (PDF)

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus

Alimentary Pharmacology & Therapeutics (Suppl), 2017-03, Vol.45 (6), p.801-813

2017

Volltextzugriff (PDF)

Systematic review: outcomes and post‐operative complications following colectomy for ulcerative colitis

Alimentary pharmacology & therapeutics, 2016-10, Vol.44 (8), p.807-816

2016

Volltextzugriff (PDF)

Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (5), p.588-595

2018

Volltextzugriff (PDF)

Systematic review with meta‐analysis: use of 5‐aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (9), p.1179-1192

2017

Volltextzugriff (PDF)

Review article: remission rates achievable by current therapies for inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2011-04, Vol.33 (8), p.870-879

2011

Volltextzugriff (PDF)

Review article: the natural history of postoperative Crohn's disease recurrence

Alimentary pharmacology & therapeutics, 2012-03, Vol.35 (6), p.625-633

2012

Volltextzugriff (PDF)

Systematic review with meta‐analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.3-13

2017

Volltextzugriff (PDF)

Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study

Alimentary Pharmacology & Therapeutics (Suppl), 2018-04, Vol.47 (7), p.906-912

2018

Volltextzugriff (PDF)

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (2), p.142-149

2017

Volltextzugriff (PDF)

Systematic review and meta‐analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.6-15

2018

Volltextzugriff (PDF)

Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseases

The American journal of gastroenterology, 2014-08, Vol.109 (8), p.1250-1256

2014

Volltextzugriff (PDF)

Systematic review: fertility in non‐surgically treated inflammatory bowel disease

Alimentary Pharmacology & Therapeutics (Suppl), 2013-10, Vol.38 (8), p.847-853

2013

Volltextzugriff (PDF)

Editorial: antigenic response to CT‐P13 and infliximab originator in IBD shows similar epitope recognition—evidence from basic science supports safe switching to biosimilars

Alimentary pharmacology & therapeutics, 2018-09, Vol.48 (5), p.574-575

2018

Volltextzugriff (PDF)

Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease

Inflammatory bowel diseases, 2011-05, Vol.17 (5), p.1073-1080

2011

Volltextzugriff (PDF)

Systematic review with meta‐analysis: malignancies with anti‐tumour necrosis factor‐α therapy in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics (Suppl), 2014-03, Vol.39 (5), p.447-458

2014

Volltextzugriff (PDF)

Letter: infliximab de‐escalation based on trough levels in patients with inflammatory bowel disease

Alimentary Pharmacology & Therapeutics (Suppl), 2015-10, Vol.42 (7), p.939-940

2015

Volltextzugriff (PDF)

Surgery for adult Crohn's disease: what is the actual risk?

Gut, 2011-09, Vol.60 (9), p.1178-1181

2011

Volltextzugriff (PDF)

Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and future

Alimentary Pharmacology & Therapeutics (Suppl), 2013-05, Vol.37 (9), p.855-866

2013

Volltextzugriff (PDF)

Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis

Alimentary Pharmacology & Therapeutics (Suppl), 2017-04, Vol.45 (8), p.1058-1072

2017

Volltextzugriff (PDF)

Systematic review and meta‐analysis: opportunistic infections and malignancies during treatment with anti‐integrin antibodies in inflammatory bowel disease

Alimentary Pharmacology & Therapeutics (Suppl), 2015-06, Vol.41 (12), p.1227-1236

2015

Volltextzugriff (PDF)

Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (2), p.219-228

2018

Volltextzugriff (PDF)

The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2014-04, Vol.39 (7), p.712-720

2014

Volltextzugriff (PDF)

1 – 25 von 931

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(737)
Mit Volltextzugriff
(779)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(308)
Humans
(293)
Life Sciences & Biomedicine
(281)
Male
(174)
Gastroenterology & Hepatology
(150)
Life Sciences
(141)
Female
(107)
Adult
(103)
Biological And Medical Sciences
(95)
Animals
(90)
Pharmacology & Pharmacy
(74)
Middle Aged
(67)
Inflammatory Bowel Disease
(59)
Medical Sciences
(56)
Rats
(55)
Crohn's Disease
(43)
Neurosciences
(43)
Neurosciences & Neurology
(43)
Ulcerative Colitis
(43)
Fundamental And Applied Biological Sciences. Psychology
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systematic review with meta‐analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials

Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis

Ulcerative proctitis: Challenges for clinical management

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus

Systematic review: outcomes and post‐operative complications following colectomy for ulcerative colitis

Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

Systematic review with meta‐analysis: use of 5‐aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease

Review article: remission rates achievable by current therapies for inflammatory bowel disease

Review article: the natural history of postoperative Crohn's disease recurrence

Systematic review with meta‐analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open‐label, prospective and randomised clinical trial

Systematic review and meta‐analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index

Development of an algorithm incorporating pharmacokinetics of adalimumab in inflammatory bowel diseases

Systematic review: fertility in non‐surgically treated inflammatory bowel disease

Editorial: antigenic response to CT‐P13 and infliximab originator in IBD shows similar epitope recognition—evidence from basic science supports safe switching to biosimilars

Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease

Systematic review with meta‐analysis: malignancies with anti‐tumour necrosis factor‐α therapy in inflammatory bowel disease

Letter: infliximab de‐escalation based on trough levels in patients with inflammatory bowel disease

Surgery for adult Crohn's disease: what is the actual risk?

Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and future

Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis

Systematic review and meta‐analysis: opportunistic infections and malignancies during treatment with anti‐integrin antibodies in inflammatory bowel disease

Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis

The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease

Suchergebnisse filtern